GGI
VIR icon

GordonMD Global Investments’s Vir Biotechnology VIR Stock Holding History

GordonMD Global Investments’s Portfolio VIR Stock Details VIR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$13.8M Sell
1,353,552
-165,000
-11% -$1.57M 6.67% 5
2026
Q1 		$13.6M Buy
1,518,552
+588,235
+63% +$4.69M 9.48% 3
2025
Q4 		$5.61M Buy
+930,317
New +$5.54M 4.02% 8

Other funds holding VIR

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AVM
Arch Venture Management Chicago, Illinois $1.1B AUM 356.62% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
SIAU
SB Investment Advisers (UK) London, United Kingdom $7.66B AUM 20.12% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
GP
GSK plc London $602M AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

GordonMD Global Investments's VIR Position: Q2 2026 in Review

GordonMD Global Investments reduced its Vir Biotechnology (VIR) stake by 11% in Q2 2026, selling an estimated $1.57M and leaving 1,353,552 shares worth $13.8M. The position accounts for 6.67% of the portfolio, ranked #5.

GordonMD Global Investments first reported a position in VIR in Q4 2025 and has held it in 3 quarters since. 237 funds tracked by Wall St. Rank hold VIR as of Q2 2026.

  • GordonMD Global Investments held 1,353,552 shares of Vir Biotechnology worth $13.8M as of Q2 2026.
  • GordonMD Global Investments sold 165,000 Vir Biotechnology shares in Q2 2026, an estimated $1.57M.
  • Vir Biotechnology made up 6.67% of GordonMD Global Investments's portfolio in Q2 2026, its #5 holding.
  • GordonMD Global Investments first reported a position in Vir Biotechnology in Q4 2025 and has held it in 3 quarters since.
  • 237 funds tracked by Wall St. Rank held Vir Biotechnology as of Q2 2026.

Based on GordonMD Global Investments's 13F filing for Q2 2026, filed 14 Aug 2026.